Marie-Hélène Leblanc

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

Eileen O’Meara, Michael McDonald, Michael Chan et al. · Canadian Journal of Cardiology · 2020 · 120 citations · Full text

Cardiomyopathy, Heart Failure, Cardiorenal Syndromes +8

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications

Gordon W. Moe, Justin A. Ezekowitz, Eileen O’Meara et al. · Canadian Journal of Cardiology · 2014 · 110 citations

Heart Failure, Cardiovascular Disease, Cardiac Care +4

Basiliximab and Rabbit Anti-thymocyte Globulin for Prophylaxis of Acute Rejection After Heart Transplantation: A Non-inferiority Trial

Michel Carrier, Marie-Hélène Leblanc, Louis P. Perrault et al. · The Journal of Heart and Lung Transplantation · 2007 · 78 citations

Heart Failure, Transplantation, Hematology +8

Hemodynamic features of the freestyle aortic bioprosthesis compared with stented bioprosthesis

Jean G. Dumesnil, Marie-Hélène Leblanc, P Cartier et al. · The Annals of Thoracic Surgery · 1998 · 68 citations

Mechanobiology, Stented Bioprosthesis, Engineering +13